Oppenheimer & Co. Inc. Trims Stock Position in Amprius Technologies, Inc. $AMPX

Key Points

• Oppenheimer & Co. trimmed its stake in Amprius by 33.4% in Q3 and now holds 299,339 shares (0.24% of the company) valued at about $3.15 million.
• Company insiders have been net sellers, disposing of 3,399,331 shares (~$37.05 million) in the past 90 days, including CEO Kang Sun's sale of 1,000,000 shares and the CTO's sale of 492,827 shares.
• Analyst sentiment is broadly positive with a consensus "Moderate Buy" and an average price target of $16.57 (seven Buys vs. one Sell), alongside recent price-target increases and fresh coverage from several firms.

Oppenheimer & Co. Inc. reduced its stake in Amprius Technologies, Inc. (NYSE:AMPX - Free Report) by 33.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 299,339 shares of the company's stock after selling 149,858 shares during the quarter. Oppenheimer & Co. Inc. owned 0.24% of Amprius Technologies worth $3,149,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Geode Capital Management LLC lifted its holdings in shares of Amprius Technologies by 167.9% during the second quarter. Geode Capital Management LLC now owns 1,593,607 shares of the company's stock worth $6,710,000 after purchasing an additional 998,649 shares during the period. Millennium Management LLC raised its position in Amprius Technologies by 94.5% during the 1st quarter. Millennium Management LLC now owns 1,396,013 shares of the company's stock worth $3,741,000 after buying an additional 678,442 shares during the last quarter. Marshall Wace LLP lifted its stake in shares of Amprius Technologies by 16.1% in the 2nd quarter. Marshall Wace LLP now owns 1,105,413 shares of the company's stock worth $4,654,000 after acquiring an additional 153,476 shares during the period. Stephens Investment Management Group LLC purchased a new stake in shares of Amprius Technologies in the third quarter valued at about $11,392,000. Finally, JPMorgan Chase & Co. increased its stake in shares of Amprius Technologies by 12,063.3% during the second quarter. JPMorgan Chase & Co. now owns 1,017,217 shares of the company's stock worth $4,282,000 after acquiring an additional 1,008,854 shares during the period. Hedge funds and other institutional investors own 5.04% of the company's stock.

Amprius Technologies Price Performance

AMPX opened at $10.17 on Friday. Amprius Technologies, Inc. has a 1-year low of $1.70 and a 1-year high of $16.03. The stock has a market cap of $1.33 billion, a P/E ratio of -39.12 and a beta of 2.99. The stock's 50 day simple moving average is $10.45 and its 200 day simple moving average is $10.27.

Insiders Place Their Bets

In other news, CEO Kang Sun sold 1,000,000 shares of Amprius Technologies stock in a transaction on Monday, November 17th. The stock was sold at an average price of $10.60, for a total transaction of $10,600,000.00. Following the completion of the transaction, the chief executive officer owned 1,472,306 shares of the company's stock, valued at $15,606,443.60. The trade was a 40.45% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CTO Constantin Ionel Stefan sold 492,827 shares of the business's stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total transaction of $5,933,637.08. Following the completion of the sale, the chief technology officer owned 748,696 shares in the company, valued at $9,014,299.84. This represents a 39.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 3,399,331 shares of company stock valued at $37,048,615. Company insiders own 12.90% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently commented on AMPX. Weiss Ratings restated a "sell (e+)" rating on shares of Amprius Technologies in a research report on Wednesday, January 21st. Cantor Fitzgerald raised their price target on Amprius Technologies from $12.00 to $16.00 and gave the company an "overweight" rating in a report on Friday, November 7th. Needham & Company LLC began coverage on Amprius Technologies in a research note on Thursday, January 29th. They issued a "buy" rating and a $20.00 price target on the stock. Oppenheimer reiterated an "outperform" rating and issued a $17.00 price objective on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Finally, Roth Mkm set a $14.00 target price on Amprius Technologies and gave the company a "buy" rating in a report on Wednesday, October 22nd. Seven equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, Amprius Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $16.57.

Amprius Technologies Company Profile

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.